us qiagen acquisition 111009
On the homepage
Vikings
Out There
Crimefighting
Mental health
Qiagen paying $90 million for U.S.-based diagnostic test maker SABiosciences
Print this story
E-mail this story
Save to del.icio.us
Share on Facebook
Share on Digg
Minnesota business by the numbers
See Minnesota's top earning companies, CEOs and non-profits
More from Business
NEW YORK - Netherlands-based diagnostic products maker Qiagen NV said Monday it is buying privately held diagnostic test maker SABiosciences Corp. for about $90 million in cash.
Qiagen said the Frederick, Md., company has about 100 employees and focuses on tests used in biomedical research and in the development of future drugs and diagnostics.
The deal is expected to close in December. Qiagen said SABiosciences will have about $24 million in sales in 2010.
Shares of Qiagen rose $1, or 4.5 percent, to $23.39 in midday trading Tuesday. The stock earlier reached a 52-week high of $23.58.
Recent Business stories
More Americans expected to travel for Thanksgiving after last year's drop; most opt for car - November 10, 2009
More Americans expected to travel for Thanksgiving after last year's drop; most opt for car - The number of Americans traveling away from home for Thanksgiving will be up only slightly this year from 2008, according to a report from the AAA auto club. More
Blog: Patent Pending
Lights out at U energy conference. Irony police notified.
Just as Lawrence Kazmerski, a top official at the National Renewable Energy Laboratory, was about to give the keynote address at the University of Minnesota's annual E3 conference at the RiverCentre in St. Paul, the lights went out, bathing the audience in darkness and a deep sense of irony.
Comment on this story | Be the first to comment | Hide reader comments